Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cronos Group (CRON) stock

Learn how to easily invest in Cronos Group stock.

Cronos Group Inc
NASDAQ: CRON - USD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
$7.29
+$0.14 (+1.96%)

Cronos Group Inc is a drug manufacturers-specialty & generic business based in the US. Cronos Group shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Cronos Group

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CRON – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cronos Group stock price (NASDAQ: CRON)

Use our graph to track the performance of CRON stocks over time.

Cronos Group shares at a glance

Information last updated 2021-07-23.
Latest market close$8.56
52-week range$4.92 - $15.83
50-day moving average $8.36
200-day moving average $9.25
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.29

Buy Cronos Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cronos Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cronos Group price performance over time

Historical closes compared with the close of $8.56 from 2021-06-03

1 week (2021-07-16) N/A
1 month (2021-06-25) -3.60%
3 months (2021-04-27) 4.26%
6 months (2021-01-23) N/A
1 year (2020-07-23) N/A
2 years (2019-07-23) N/A
3 years (2018-07-23) N/A
5 years (2016-07-23) N/A

Cronos Group financials

Revenue TTM $50.9 million
Gross profit TTM $-25,833,000
Return on assets TTM -5.51%
Return on equity TTM -19%
Profit margin 0%
Book value $4.23
Market capitalisation $2.7 billion

TTM: trailing 12 months

Shorting Cronos Group shares

There are currently 20.9 million Cronos Group shares held short by investors – that's known as Cronos Group's "short interest". This figure is 3.5% down from 21.7 million last month.

There are a few different ways that this level of interest in shorting Cronos Group shares can be evaluated.

Cronos Group's "short interest ratio" (SIR)

Cronos Group's "short interest ratio" (SIR) is the quantity of Cronos Group shares currently shorted divided by the average quantity of Cronos Group shares traded daily (recently around 3.0 million). Cronos Group's SIR currently stands at 7.05. In other words for every 100,000 Cronos Group shares traded daily on the market, roughly 7050 shares are currently held short.

However Cronos Group's short interest can also be evaluated against the total number of Cronos Group shares, or, against the total number of tradable Cronos Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos Group's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Cronos Group shares in existence, roughly 60 shares are currently held short) or 0.1067% of the tradable shares (for every 100,000 tradable Cronos Group shares, roughly 107 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cronos Group.

Find out more about how you can short Cronos Group stock.

Cronos Group share dividends

We're not expecting Cronos Group to pay a dividend over the next 12 months.

Cronos Group share price volatility

Over the last 12 months, Cronos Group's shares have ranged in value from as little as $4.915 up to $15.83. A popular way to gauge a stock's volatility is its "beta".

CRON.US volatility(beta: 1.8)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos Group's is 1.8028. This would suggest that Cronos Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cronos Group overview

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc.

Stocks similar to Cronos Group

Frequently asked questions

What percentage of Cronos Group is owned by insiders or institutions?
Currently 47.233% of Cronos Group shares are held by insiders and 16.856% by institutions.
When does the fiscal year end for Cronos Group?
Cronos Group's fiscal year ends in December.
Where is Cronos Group based?
Cronos Group's address is: 111 Peter Street, Toronto, ON, Canada, M5V 2H1
What is Cronos Group's ISIN number?
Cronos Group's international securities identification number is: CA22717L1013
What is Cronos Group's CUSIP number?
Cronos Group's Committee on Uniform Securities Identification Procedures number is: 226903102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site